The Global Health Symposium Series
The goal of the Global Health Symposium Series, hosted each year by the JHUSOM Global Health Interest Group (GHIG), is to foster dialog and interaction between leaders in global health (both established as well as rising) and engaged students here at Johns Hopkins University
Symposium 6 (Global Health Day): The Health Impact Fund: Boosting Innovation Without Obstructing Free Access (Thursday, April 5th, 2012: 5:30-7:00 p.m., Sheldon Hall, JHSPH)
Thomas Pogge, PhD, is Leitner Professor of Philosophy and International Affairs and Director of the Global Justice Program at Yale University. Originally from Germany, Thomas Pogge received a PhD in philosophy from Harvard in 1983. Since then, he has taught philosophy, political science, and ethics at universities around the world. His 2002 book, World Poverty and Human Rights, offers proposals on how to achieve global economic equality. In 2008, he co-authored the Health Impact Fund, which lays out the plan to make life-saving medicines accessible for everyone. In addition to his position at Yale, Dr. Pogge also holds appointments at University of Oslo, Australian National University and the University of Central Lancashire.
Symposium 5: Global Epidemics of HIV among Men Who Have Sex With Men (Wednesday, December 15th, 2011: 5:30-7:00 p.m., Cader Room, JHH)
Chris Beyrer, MD, MPH, Founder and Director, the Center for Public Health and Human Rights (JHSPH), Professor in the Departments of Epidemiology, International Health, and Health, Behavior & Society, and Director of the Johns Hopkins Fogarty AIDS International Training and Research Program. Dr. Beyrer serves on the Governing Council of the International AIDS society and was recently appointed to the Scientific Advisory Board of the President’s Emergency Plan for AIDS Relief (PEPFAR). Dr. Beyrer’s research interests focus on the burden of HIV and other infectious diseases and the association with human rights, with specific interests in epidemiology among high risk or marginalized populations, prevention research, and molecular epidemiology. He currently has research and/or training activities in Thailand, Burma, Malawi, Uganda, Ethiopia, South Africa, Brazil, Russia, Kazakhstan, and the US.
Symposium 4: Viral Reaction: Emerging Disease in Our Increasingly Connected Society (Co-sponsored with the Hopkins Medicine Distinguished Speaker Series [HMDSS] Monday, November 7th, 2011: 4:00-5:30 p.m., Armstrong Medical Education Building)
Anthony S. Fauci, MD, was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. Fauci serves as one of the key advisors to the White House and Department of Health and Human Services on global AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats such as pandemic influenza.
Symposium 3: Politics, Partnerships and Principles: Ethical Issues in Conducting HIV Clinical Trials Abroad (Monday, October 10th, 2011: 5:30 – 7:00 p.m., Cader Room, JHH)
This event was a panel discussion with three distinguished faculty involved in the seminal HPTN 052 HIV Prevention Trial:
Joel E. Gallant, MD, MPH is Associate Professor of Medicine in the Division of Infectious Diseases at JHUSOM, Associate Director of the Johns Hopkins AIDS Service, and Associate Professor of Epidemiology at JHSPH. His primary areas of interest include conducting clinical trials of new antiretroviral agents (phase 2-4), both in the United States and in developing countries, as well as research on the natural history of HIV infection and its complications. Dr. Gallant is an investigator in the HIV Prevention Trials Network (HPTN), the Acute Infection Early Disease Research Program (AIEDRP), the Multicenter AIDS Cohort (MACS), and the AIDS Clinical Trials Group (ACTG). Within the HPTN and ACTG he has been involved in international clinical trials, especially in Chiang Mai, Thailand. Dr. Gallant did his MD at UCSF, his residency at Yale, and his MPH and fellowship in infectious diseases at JHU.
Amita Gupta, MD, MHS, is Assistant Professor of Infectious Diseases at JHUSOM and Deputy Director, JHU Center for Clinical Global Health Education (CCGHE). As an HIV clinician and ID physician, Dr. Gupta has done substantial work abroad in countries that include Guatemala, Vietnam, Micronesia and India. She is an active investigator in multi-country HIV trials conducted by the AIDS Clinical Trials Group (ACTG), HIV Prevention Trials Network (HPTN) and International Maternal Pediatric Adolescent AIDS Trials Network (IMPAACT) focusing on HIV, TB and other co-morbidities and treatment outcomes in adults (including pregnant women) and children. Dr. Gulta did her MD at Harvard, her residency at UCSF, and her fellowship in infectious diseases and MHS in public health at JHU.
Jeremy Sugarman, MD, MPH, MA, is Harvey M. Meyerhoff Professor of Bioethics and Medicine and Deputy Director for Medicine at the Berman Institute of Bioethics at Johns Hopkins. Dr. Sugarman is an internationally recognized leader in the field of biomedical ethics with particular expertise in the application of empirical methods and evidence-based standards for the evaluation and analysis of bioethical issues. His contributions to both medical ethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, and research oversight. He has authored over 200 articles, reviews, and book chapters on these subjects and others. Dr. Sugarman did his medical degree and residency at Duke, his MA in bioethics at Georgetown, and his MPH and fellowship in general internal medicine at JHU.
Symposium 2: Trends in Global Health and Ending the Neglect (Wednesday, February 2nd, 2011: 5:30 – 7:00 p.m., Cader Room, JHH)
Neeraj Mistry, MD, MS, has been the Managing Director of the Global Network for Neglected Tropical Diseases at the Sabin Vaccine Institute since July 2010. After completing his medical training at the University of the Witwatersrand Medical School in Johannesburg, South Africa, Dr. Mistry focused on HIV/AIDS, occupational health, family practice and sexual and reproductive health. He also holds a Master’s degree in health policy and economics from the London School of Economics and Political Science. A public health physician, Dr. Mistry was a founding member and former vice president of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC), and brings extensive experience in global health policy and programming. He has worked in developing and developed countries, in the public and private sectors, in clinical practice, health policy and social development.
Symposium 1: Conflicting Loyalties in Medicine: Physicians, Torture, and Human Rights (Tuesday, October 26th, 2010: 5:30 – 7:00 p.m., Cader Room, JHH)
Leonard S. Rubenstein, JD, is a Senior Scientist at the Johns Hopkins Bloomberg Center for Human Rights and Public Health. A graduate of Harvard Law School and Wesleyan University, Mr. Rubenstein has spent thirty years engaged in scholarship and advocacy in human rights and health. For twelve years he served as Executive Director and then President of Physicians for Human Rights and prior to that as Executive Director of the Bazelon Center for Mental Health Law. He spent the 2008-09 academic year as a Senior Fellow at the United States Institute of Peace. His work has embraced human rights and mental health, human experimentation, health systems in low-income and post-conflict countries, race and ethnic disparities in health care, health professional engagement in interrogation and torture, protection of health in armed conflict, and divided loyalties among clinicians between patients and the state. He has written extensively both for scholarly publications and major media. Mr. Rubenstein is a member of the Council of Foreign Relations and the Committee on Scientific Freedom and Responsibility of the American Association for the Advancement of Science. He serves on the Board of Directors of the International Federation of Health and Human Rights Organizations and the Governing Council of the American Public Health Association. He is recipient of numerous awards.
